These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4804451)

  • 1. Changes in glucose tolerance, insulin, serum lipids and lipoproteins in patients with renal failure on intermittent haemodialysis.
    Arora KK; Atkinson MK; Trafford JA; Sheldon J; Nunn R
    Postgrad Med J; 1973 May; 49(571):293-6. PubMed ID: 4804451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Levels of serum lipids and lipoproteins in renal disease].
    Synková J; Groh J; Sedová J; Mejtská M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1981; 24(3):373-84. PubMed ID: 6977835
    [No Abstract]   [Full Text] [Related]  

  • 3. Observations on lipid metabolism in chronic renal failure, during conservative and haemodialysis therapy.
    Noverini A; Zuliani U; Bandini L; Caronna S; Montanari A; Perinotto P
    Eur J Clin Invest; 1976 Nov; 6(6):473-6. PubMed ID: 1001351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipaemic profile of patients subjected to long-term haemodialysis and acute changes associated with haemodialysis and the use of heparin (author's transl)].
    Koslík S; Takác M
    Sb Lek; 1981 Jul; 83(6-7):162-8. PubMed ID: 7268304
    [No Abstract]   [Full Text] [Related]  

  • 5. Early changes of plasma lipid status and glucose tolerance during the course of chronic renal failure.
    Grützmacher P; Radtke HW; Schifferdecker E; Peschke B; Riepenhausen J; Fassbinder W; Schoeppe W
    Contrib Nephrol; 1984; 41():332-6. PubMed ID: 6525852
    [No Abstract]   [Full Text] [Related]  

  • 6. Abnormal lipoprotein in uraemic patients treated conservatively and by maintenance haemodialysis.
    Alam SM; Bhatt AK
    J Assoc Physicians India; 1991 Feb; 39(2):170-1. PubMed ID: 1885478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipid metabolism disorders in chronic kidney failure].
    Lacour B; Roullet JB; Drueke T
    Nephrologie; 1983; 4(2):75-83. PubMed ID: 6348572
    [No Abstract]   [Full Text] [Related]  

  • 9. [Renal insufficiency and carbohydrates and lipids].
    Kobayashi F; Okamoto T; Koitabashi T; Ota T; Isoda K
    Nihon Rinsho; 1974 Mar; 32(3):505-17. PubMed ID: 4603796
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
    Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
    Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of patients with atherosclerosis and renal disease with respect to lipoprotein types, fibrinolysis, and carbohydrate tolerance.
    Wardle EN; Menon IS; Anderson J
    Q J Med; 1972 Jan; 41(161):15-23. PubMed ID: 5070986
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma lipoprotein patterns in patients receiving dialysis therapy for chronic renal failure.
    Cramp DG; Tickner TR; Varghese Z; Beale DJ; Moorhead JF; Wills MR
    Clin Chim Acta; 1977 Apr; 76(2):233-6. PubMed ID: 862197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein profile in dialysis and transplant patients.
    Lau YK; Woo KT; Lim CH
    Singapore Med J; 1985 Apr; 26(2):193-7. PubMed ID: 3898396
    [No Abstract]   [Full Text] [Related]  

  • 14. Abnormal fat metabolism in chronic renal failure.
    Romics L; Makó J
    Acta Med Acad Sci Hung; 1978; 35(3-4):233-40. PubMed ID: 227218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipids and lipoproteins in acute renal failure.
    Mydlík M; Ahlers I; Derzsiová K; Takác M
    Proc Eur Dial Transplant Assoc; 1976; 12():389-96. PubMed ID: 180523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vitamin A and lipids in serum during long term dialysis program].
    Mydlík M; Derzsiová K; Ahlers I; Hildebrand T; Takác M
    Z Urol Nephrol; 1977 May; 70(5):339-44. PubMed ID: 408996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipid metabolism and lipid utilization in renal failure].
    Druml W; Laggner A; Lenz K; Balcke P; Kleinberger G; Schmidt P
    Infusionsther Klin Ernahr; 1983 Aug; 10(4):206-12. PubMed ID: 6618660
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
    Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
    Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipids in chronic renal failure.
    Wochos DN; Anderson CF; Mitchell JC
    Mayo Clin Proc; 1976 Oct; 51(10):660-4. PubMed ID: 966817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma lipids in patients with chronic renal failure.
    Kaye JP; Moorhead JF; Wills MR
    Clin Chim Acta; 1973 Mar; 44(3):301-5. PubMed ID: 4348484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.